Amanote Research
Register
Sign In
Clinicopathological Significance of DAPK Promoter Methylation in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Cancer Management and Research
- New Zealand
doi 10.2147/cmar.s174815
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
December 1, 2018
Authors
Yan Zhang
Jiang Wu
Gui Huang
Shouming Xu
Publisher
Informa UK Limited
Related search
Prognostic Significance of DAPK Promoter Methylation in Lymphoma: A Meta-Analysis
PLoS ONE
Multidisciplinary
Clinicopathological and Prognostic Significance of Oct-4 Expression in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
The Clinicopathological Significance of hMLH1 Hypermethylation in Non-Small-Cell Lung Cancer: A Meta-Analysis and Literature Review
OncoTargets and Therapy
Oncology
Pharmacology
Clinicopathological Significance and a Potential Drug Target of RARβ In Non-Small-Cell Lung Carcinoma: A Meta-Analysis and a Systematic Review
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-Small Cell Lung Cancer: A meta-Analysis
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
A Systematic Review and Meta-Analysis: Association Between MGMT Hypermethylation and the Clinicopathological Characteristics of Non-Small-Cell Lung Carcinoma
Scientific Reports
Multidisciplinary
The Clinicopathological Significance of CDH1 in Gastric Cancer: A Meta-Analysis and Systematic Review
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Prognostic Significance of Immune Cells in Non-Small Cell Lung Cancer: Meta-Analysis
Oncotarget
Oncology
Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
